Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Faaz-XT is an oral nutraceutical supplement marketed by Kaviva Life Sciences, an Indian company specializing in fertility-related health products. It is a combination formulation containing ferrous ascorbate, folic acid, and zinc sulphate. Ferrous ascorbate is a synthetic molecule of iron and ascorbic acid used to treat iron deficiency anemia due to its high absorption rate. Folic acid (Vitamin B9) is essential for DNA synthesis and fetal development, while zinc sulphate provides elemental zinc, a cofactor for numerous enzymes involved in growth and immune function. The product is available in various dosage forms, including tablets, drops, and syrups, and is primarily used to address nutritional deficiencies and support reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Faaz-XT.